01 June 2022 | News
Clinical Specimens to be sent to NIV Pune Apex Laboratory through Integrated Disease Surveillance Programme network
Image credit: WHO
In view of the increasing reports of Monkeypox (MPX) cases in non-endemic countries, as part of a proactive and risk-based approach for management of Monkeypox and to ensure advance preparedness across the country, Union Ministry of Health and Family Welfare has issued ‘Guidelines on Management of Monkeypox Disease’.
There are no reported cases of monkey pox disease in India, as on date.
As per the Guidelines, a confirmed case is laboratory confirmed for monkeypox virus by detection of unique sequences of viral DNA either by polymerase chain reaction (PCR) and/or sequencing. All the clinical specimens should be transported to the Apex Laboratory of ICMR-NIV (Pune) routed through the Integrated Disease Surveillance Programme (IDSP) network of the respective district/state.
The Guidelines on Management of Monkeypox Disease include epidemiology of the disease including host, incubation period, period of communicability and mode of transmission; contact and case definitions; clinical features and its complication, diagnosis, case management, risk communication, guidance on Infection Prevention and Control (IPC) including use of personal protective equipment
The guidelines stresses on surveillance and rapid identification of new cases as the key public health measures for outbreak containment, mandating need to reduce the risk of human-to-human transmission. It explains the Infection Prevention and Control (IPC) measures, IPC at home, patient isolation and ambulance transfer strategies, additional precautions that needs to be taken care of and duration of isolation procedures.